Industry perspectives on regulating innovative medicines
- At: 2017 FIP Congress in Stockholm (Sweden)
- Type: Presentation
- By: SCHEEREN, Joseph (Bayer Consumer Care AG, Regulatory Affairs Pharma & Consumer Health, Basel, Switzerland)
- Co-author(s): Joseph Scheeren: Regulatory Affairs Pharma & Consumer Health, Bayer Consumer Care AG, Basel, Switzerland
In a globalizing pharmaceutical world with empowered patients the commitment for enabling early patient access to new innovative medicines is one of the major challenges for the industry and the regulators. Initiatives like ICH (International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use).. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.